top of page
About

Next-Gen 
Tumor Models 

For Research & Drug Development.

cancer_cell_and_T_lymphocytes-5a28416422fa3a0037111149-removebg-preview.png
image (1).png

The Challenge

Close to 95% of new cancer drugs fail during clinical trials. Drug development has also become slower and more expensive in a phenomenon known as Erooms Law. One of the root causes of these problems is that the tools researchers use for efficacy testing, such as 2D cell cultures and murine models, do not accurately depict human biology.

vector-abstract-business-blue-wavy-background_edited.jpg

OUR SOLUTION
 TUMOROIDS-ON-A-CHIP

IMG-5656_edited_edited_edited.jpg

3-in-1 Plate

ADVANTAGES

  • Tumor models + extracellular matrix + drug testing. All-in-one platform.

  • Uniform tumor models.

  • In situ IHC analysis.

  • Effortless on-plate immunostaining and imaging.

  • Only one tumoroid per well, eliminating the possibility of inter-model crosstalk. 

IMG_4790_edited_edited_edited_edited_edi

EZ-Seed Plate

ADVANTAGES

  • One step cell seeding.

  • Monosize spheroids for experimental consistency.

  • Effortless immunostaining and imaging.

  • Platform is directly embeddable in paraffin for IHC and H&E analysis. 

Our Partners

Research Institutes and Universities

Pre-clinical CROs

Pharma and Drug Developers

download_edited.jpg
testing-vaccines-black-glyph-icon-laboratory-research-producing-safe-and-effective-vaccine
university-icon-symbol-creative-sign-from-vector-26747111_edited.jpg

2

1

10

Tumor spheroids and organoids

What Are Tumoroids?

Tumoroids are three dimensional clusters of tumor cells grown in vitro. They are also known as tumor spheroids or organoids. These structures mimic important aspects of the tumor microenvironment such as cell-cell and cell-matrix interactions, making them important models for both basic cancer research and drug testing. They are also amenable to a wide variety of assays and cancer/cell types. 

Rewriting Erooms Law.

bottom of page